FBTAX Holdings Information

FBTAX is a mutual fund with a total of 92 individual holdings. The top holdings are AbbVie stock at 16.61%, Gilead Sciences at 6.57%, Alnylam Pharmaceuticals at 5.02%, Ascendis Pharma at 4.49%, and Cogent Biosciences at 3.83%.

Total Holdings

Top 10 Percentage

52.39%

Asset Class

Equity

Fund Category

Health

Assets

1.90B

Forward PE Ratio

17.81

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	16.61%	1,389,580
2	GILD	Gilead Sciences, Inc.	6.57%	864,100
3	ALNY	Alnylam Pharmaceuticals, Inc.	5.02%	277,186
4	ASND	Ascendis Pharma A/S	4.49%	370,625
5	COGT	Cogent Biosciences, Inc.	3.83%	1,988,418
6	ARGX	argenx SE	3.65%	81,000
7	INSM	Insmed Incorporated	3.47%	412,300
8	VRDN	Viridian Therapeutics, Inc.	3.15%	1,782,464
9	BIIB	Biogen Inc.	2.84%	294,100
10	AMGN	Amgen Inc.	2.76%	150,703
11	PCVX	Vaxcyte, Inc.	2.29%	796,329
12	GPCR	Structure Therapeutics Inc.	2.28%	481,200
13	NUVL	Nuvalent, Inc.	2.27%	412,264
14	DNTH	Dianthus Therapeutics, Inc.	2.09%	730,062
15	AMLX	Amylyx Pharmaceuticals, Inc.	1.86%	2,433,200
16	MRNA	Moderna, Inc.	1.59%	674,300
17	APGE	Apogee Therapeutics, Inc.	1.59%	452,639
18	XENE	Xenon Pharmaceuticals Inc.	1.56%	710,758
19	CRNX	Crinetics Pharmaceuticals, Inc.	1.46%	544,470
20	PRAX	Praxis Precision Medicines, Inc.	1.45%	86,400
21	SRRK	Scholar Rock Holding Corporation	1.38%	582,368
22	ORKA	Oruka Therapeutics, Inc.	1.30%	710,786
23	SYRE	Spyre Therapeutics, Inc.	1.28%	749,342
24	EBR: UCB	UCB SA	1.23%	75,800
25	QURE	uniQure N.V.	1.21%	991,600

Showing 25 of 92 holdings

Subscribe to see the full list

Activate Now

As of Jan 31, 2026